Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

ConditionStroke, Acute
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSantiago Ortega Gutierrez

About this trial

The purpose of this study is to compare two strategies for treating adults with suspected large vessel occlusion stroke within 7 hours of symptom onset. Researchers will evaluate whether direct transfer to the neurointerventional angiography suite improves recovery and reduces disability compared to the conventional approach of first being evaluated in the emergency department. The study will also assess safety and other health outcomes to guide care for stroke patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: ≥ 18 years of age.

Clinical Presentation: Present to a participating TSC with signs or symptoms suggestive of acute LVO stroke.

Stroke Severity: Baseline NIHSS of 10 or higher.

Time since LKW: Time from LKW to arrival at the TSC must be within 7 hours.

Disqualifiers

Time Restrictions: Presentation to a thrombectomy-capable center more than 7 hours from LSW.

Imaging Criteria for Interfacility Transfer Patients: At sites enrolling transfer patients, any patient arriving from an outside hospital with time from imaging study at the presenting hospital to arrival at the TSC not exceeding 90 minutes.

Hemorrhagic Stroke: Presence of intracranial hemorrhage on brain imaging in the conventional strategy as Heidelberg that renders thrombectomy contraindicated.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Conventional Triage for Mechanical Thrombectomy

    Other intervention

    Participants undergo the conventional standard-of-care triage process. Upon arrival at the thrombectomy-capable center, patients first undergo an initial evaluation in the emergency department (ED), which includes diagnostic imaging (CT or MRI) to confirm eligibility for mechanical thrombectomy (MT). If the patient is found to have a large vessel occlusion (LVO) suitable for thrombectomy, they are transferred to the neurointerventional suite for treatment.

  • Direct Transfer to Angiography Suite (DTAS

    Other intervention

    Patients who arrive at the thrombectomy-capable center (from home, mobile stroke units, or interfacility transfer) are immediately transferred to the neurointerventional suite, bypassing the emergency department (ED). Upon arrival in the neurointerventional suite, initial neuroimaging (typically using flat panel CT or other imaging modalities) is conducted to confirm the presence of a large vessel occlusion (LVO). If the patient is eligible for mechanical thrombectomy (MT), treatment is initiated directly in the angiography suite. This approach aims to reduce delays in care and improve clinical outcomes by providing faster access to thrombectomy treatment.

Treatment groups

2,039 Participants
are divided into 2 treatment groups
Group A: Conventional Triage ArmActive comparator 1 intervention
Group B: Direct Transfer to Angiography Suite (DTAS) ArmActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Global Disability at 90 Days

Global disability will be measured using the disability-weighted modified Rankin Scale (dw-mRS) at 90 days (±14 days) post-stroke. The dw-mRS is a validated tool assessing the severity of disability across seven levels, from no symptoms (0) to severe disability or death (6). This outcome evaluates whether the direct transfer to the angiography suite (DTAS) strategy results in improved functional outcomes compared to the conventional triage strategy.

Time frame
90 days (±14 days)

Secondary outcomes

1

Functional Independence at 90 Days

The proportion of patients achieving functional independence, measured by a dichotomized modified Rankin Scale score (mRS 0-2), assessed during the in-hospital stay and at 90 (±14) days after treatment.

Time frame
90 (±14) days.
2

Stroke Workflow Efficiency

Metrics include door-to-puncture times, door-to-reperfusion times, and rates of intravenous thrombolysis administration, evaluating the time taken to perform key steps in stroke workflow.

Time frame
Immediately post procedure
3

Procedural Success

Reperfusion rates of the large vessel occlusion (LVO) using the Extended Thrombolysis in Cerebral Ischemia (eTICI) scale, with successful reperfusion defined as mTICI 2b-3.

Time frame
Immediately post-procedure.
4

Cognitive Ability

Assessed at 90 days using the Montreal Cognitive Assessment (MoCA), measuring domains such as memory, attention, and executive function.

Time frame
90 (±14) days.

Other outcomes

1

Global Disability

Disability measured by all seven ordinal levels of the modified Rankin Scale (mRS) at hospital discharge.

Time frame
Immediately at discharge.
2

Instrumental Activities of Daily Living

Measured at 90 days using the Barthel Index, assessing the patient's ability to perform daily activities independently.

Time frame
90 (±14) days.
3

Caregiving Burden

Caregiving burden assessed using Zarit's Burden Interview (ZBI) at 90 days, evaluating the impact of stroke on caregivers.

Time frame
90 (±14) days.
4

Healthcare Utilization

Assessed by metrics such as length of hospital stay, home-time, and number of days spent at initial residency level within 90 days post-stroke.

Time frame
90 (±14) days.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Santiago Ortega Gutierrez

Lead sponsor

University of Iowa

Sponsor institution

Patient-Centered Outcomes Research Institute

Collaborator